Hoogendoorn M - Search Results

1

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP. Hoogendoorn M, et al. Thorax. 2010 Aug;65(8):711-8. doi: 10.1136/thx.2009.131631. Thorax. 2010. PMID: 20685746 Free article. Review.

2

Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice.

Hoogendoorn M, Feenstra TL, Schermer TR, Hesselink AE, Rutten-van Mölken MP. Hoogendoorn M, et al. Respir Med. 2006 Jan;100(1):83-6. doi: 10.1016/j.rmed.2005.04.004. Respir Med. 2006. PMID: 15894477 Free article.

3

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.

Hoogendoorn M, Welsing P, Rutten-van Mölken MP. Hoogendoorn M, et al. Curr Med Res Opin. 2008 Jan;24(1):51-61. doi: 10.1185/030079908x242917. Curr Med Res Opin. 2008. PMID: 18021492

4

Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial.

van Wetering CR, van Nooten FE, Mol SJ, Hoogendoorn M, Rutten-Van Mölken MP, Schols AM. van Wetering CR, et al. Among authors: hoogendoorn m. Int J Chron Obstruct Pulmon Dis. 2008;3(3):443-51. doi: 10.2147/copd.s2588. Int J Chron Obstruct Pulmon Dis. 2008. PMID: 18990973 Free PMC article. Clinical Trial.

5

Holistic preferences for 1-year health profiles describing fluctuations in health: the case of chronic obstructive pulmonary disease.

Rutten-van Mölken MP, Hoogendoorn M, Lamers LM. Rutten-van Mölken MP, et al. Among authors: hoogendoorn m. Pharmacoeconomics. 2009;27(6):465-77. doi: 10.2165/00019053-200927060-00003. Pharmacoeconomics. 2009. PMID: 19640010

6

Self-report versus care provider registration of healthcare utilization: impact on cost and cost-utility.

Hoogendoorn M, van Wetering CR, Schols AM, Rutten-van Mölken MP. Hoogendoorn M, et al. Int J Technol Assess Health Care. 2009 Oct;25(4):588-95. doi: 10.1017/S0266462309990432. Int J Technol Assess Health Care. 2009. PMID: 19845991

7

Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial.

van Wetering CR, Hoogendoorn M, Broekhuizen R, Geraerts-Keeris GJ, De Munck DR, Rutten-van Mölken MP, Schols AM. van Wetering CR, et al. Among authors: hoogendoorn m. J Am Med Dir Assoc. 2010 Mar;11(3):179-87. doi: 10.1016/j.jamda.2009.12.083. Epub 2010 Feb 4. J Am Med Dir Assoc. 2010. PMID: 20188315 Clinical Trial.

8

Association between lung function and exacerbation frequency in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Mölken MR. Hoogendoorn M, et al. Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 21191438 Free PMC article. Review.

9

Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.

Hoogendoorn M, Rutten-van Mölken MP, Hoogenveen RT, Al MJ, Feenstra TL. Hoogendoorn M, et al. Value Health. 2011 Dec;14(8):1039-47. doi: 10.1016/j.jval.2011.06.008. Epub 2011 Sep 22. Value Health. 2011. PMID: 22152172 Free article.

10

Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial.

Hoogendoorn M, Al MJ, Beeh KM, Bowles D, Graf von der Schulenburg JM, Lungershausen J, Monz BU, Schmidt H, Vogelmeier C, Rutten-van Mölken MP. Hoogendoorn M, et al. Eur Respir J. 2013 Mar;41(3):556-64. doi: 10.1183/09031936.00027212. Epub 2012 Jun 14. Eur Respir J. 2013. PMID: 22700844 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page